Cited by 652Phosphodiesterase function and regulationSchizophrenia research and treatmentProtein Tyrosine Phosphatases

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling

Millar, J. Kirsty, Pickard, Benjamin S., Mackie, Shaun, James, Rachel, Christie, Sheila, Buchanan, Sebastienne R., Malloy, M. Pat, Chubb, Jennifer E., Huston, Elaine, Baillie, George S., Thomson, Pippa A., Hill, Elaine V., Brandon, Nicholas J., Rain, Jean-Christophe, Camargo, L. Miguel, Whiting, Paul J., Houslay, Miles D., Blackwood, Douglas H. R., Muir, Walter J., Porteous, David J.·2005·Science

DOI 10.1126/science.1112915

Open this paper in CoChat — free account

Abstract

The disrupted in schizophrenia 1 ( DISC1 ) gene is a candidate susceptibility factor for schizophrenia, but its mechanistic role in the disorder is unknown. Here we report that the gene encoding phosphodiesterase 4B ( PDE4B ) is disrupted by a balanced translocation in a subject diagnosed with schizophrenia and a relative with chronic psychiatric illness. The PDEs inactivate adenosine 3′,5′-monophosphate (cAMP), a second messenger implicated in learning, memory, and mood. We show that DISC1 interacts with the UCR2 domain of PDE4B and that elevation of cellular cAMP leads to dissociation of PDE4B from DISC1 and an increase in PDE4B activity. We propose a mechanistic model whereby DISC1 sequesters PDE4B in resting cells and releases it in an activated state in response to elevated cAMP.

Integrity signals

Registry

Crossref · 10.1126/science.1112915

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Disruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254
Self-citation
PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization
Houslay, M. D., & Adams, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 768
Self-citation
Schizophrenia and Affective Disorders—Cosegregation with a Translocation at Chromosome 1q42 That Directly Disrupts Brain-Expressed Genes: Clinical and P300 Findings in a Family
Blackwood, D., Fordyce, A., Walker, M. T., Clair, D. M. S., Porteous, D. J., & Muir, W. J. (2001) · The American Journal of Human Genetics · doi:10.1086/321969 · Cited by 734
Self-citation
Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase
Sette, C., & Conti, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16526 · Cited by 412
Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth
Miyoshi, K., Honda, A., Baba, K., Taniguchi, M., Oono, K., Fujita, T., Kuroda, S., Katayama, T., & Tohyama, M. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001352 · Cited by 314
Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)
O’Donnell, J. M., & Zhang, H. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.003 · Cited by 307
Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A‐mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1)
MacKenzie, S. J., Baillie, G. S., McPhee, I., MacKenzie, C., SEAMONS, R. A., McSorley, T., Millen, J. E., Beard, M., Heeke, G. V., & Houslay, M. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704743 · Cited by 261
Self-citation
Antidepressant-like Profile and Reduced Sensitivity to Rolipram in Mice Deficient in the PDE4D Phosphodiesterase Enzyme
Zhang, H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00344-5 · Cited by 228
Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders
Brandon, N. J., Handford, E. J., Schurov, I., Rain, J., Pelling, M., Duran-Jimenez, B., Camargo, L. M., Oliver, K. R., Beher, D., Shearman, M. S., et al. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.09.009 · Cited by 224
Self-citation

Flagged first, then by citations

Show all 20 references

Research works printed but not linked: 2

C. P. Austin, L. Ma, B. Ky, J. A. Morris, P. J. Shugrue, Neuroreport14, 951 (2003).
H. T. Zhang et al., Neuropsychopharmacology27, 587 (2002).

Sorted by citations

Items 101–200 of 652

PDE inhibitors in psychiatry – future options for dementia, depression and schizophrenia?
Halene, T. B., & Siegel, S. J. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.023 · Cited by 122
The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review
Dahoun, T., Trossbach, S. V., Brandon, N., Korth, C., & Howes, O. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.282 · Cited by 118
Self-citation
A Cytogenetic Abnormality and Rare Coding Variants Identify ABCA13 as a Candidate Gene in Schizophrenia, Bipolar Disorder, and Depression
Knight, H. M., Pickard, B. S., Maclean, A. W., Malloy, M. P., Soares, D. C., McRae, A. F., Condie, A., White, A., Hawkins, W., McGhee, K. A., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.11.003 · Cited by 123
Self-citation
Advances in the Development of Phosphodiesterase-4 Inhibitors
Peng, T., Qi, B., He, J., Ke, H., & Shi, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02170 · Cited by 118
Genomic DISC1 Disruption in hiPSCs Alters Wnt Signaling and Neural Cell Fate
Srikanth, P., Han, K., Callahan, D. G., Makovkina, E., Muratore, C., Lalli, M. A., Zhou, H., Boyd, J. D., Kosik, K. S., Selkoe, D. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.061 · Cited by 119
Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder
Pickard, B. S., Malloy, M. P., Christoforou, A., Thomson, P. A., Evans, K. L., Morris, S. W., Hampson, M. E., Porteous, D. J., Blackwood, D., & Muir, W. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001867 · Cited by 116
Self-citation
Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer
Ngô, H. M., Zhou, Y., Lorenzi, H., Wang, K., Kim, T., Zhou, Y. F., Bissati, K. E., Mui, E. J., Fraczek, L., Rajagopala, S. V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10675-6 · Cited by 114
Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia
Ikeda, M., Hikita, T., Taya, S., Uraguchi‐Asaki, J., Toyo‐oka, K., Wynshaw-Boris, A. J., Ujike, H., Inada, T., Takao, K., Miyakawa, T., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn217 · Cited by 111
DISC1 genetics, biology and psychiatric illness
Thomson, P. A., Malavasi, E. L. V., Grünewald, E., Soares, D. C., Borkowska, M., & Millar, J. K. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1254-7 · Cited by 112
Self-citation
Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme
Siuciak, J., McCarthy, S. A., Chapin, D., & Martin, A. N. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1014-6 · Cited by 111
Lessons from studying monogenic disease for common disease
Peltonen, L., Perola, M., Naukkarinen, J., & Palotie, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl060 · Cited by 105
Disrupted-in-Schizophrenia-1 expression is regulated by β-site amyloid precursor protein cleaving enzyme-1–neuregulin cascade
Seshadri, S., Kamiya, A., Yokota, Y., Prikulis, I., Kano, S., Hayashi‐Takagi, A., Stanco, A., Eom, T.-Y., Rao, S., Ishizuka, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909284107 · Cited by 110
Structural basis for the design of selective phosphodiesterase 4B inhibitors
Fox, D. N. A., Burgin, A. B., & Gurney, M. E. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.12.003 · Cited by 109
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
Bhat, A., Ray, B., Mahalakshmi, A. M., Tuladhar, S., Nandakumar, D., Srinivasan, M., Essa, M. M., Chidambaram, S. B., Guillemin, G. J., & Sakharkar, M. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105078 · Cited by 109
Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness
Millar, J. K., Mackie, S., Clapcote, S., Murdoch, H., Pickard, B., Christie, S., Muir, W., Blackwood, D. H. R., Roder, J., Houslay, M., et al. (2007) · Journal of Physiology · doi:10.1113/jphysiol.2007.140210 · Cited by 109
Self-citation
Phosphodiesterases in the Central Nervous System: Implications in Mood and Cognitive Disorders
Xu, Y., Zhang, H., & O’Donnell, J. M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_19 · Cited by 104
DISC1 Regulates Neurotrophin-Induced Axon Elongation via Interaction with Grb2
Shinoda, T., Taya, S., Tsuboi, D., Hikita, T., Matsuzawa, R., Kuroda, S., Iwamatsu, A., & Kaibuchi, K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3825-06.2007 · Cited by 104
Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)–HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes
Sin, Y. Y., Edwards, H. V., Li, X., Day, J. P., Christian, F., Dunlop, A. J., Adams, D. R., Zaccolo, M., Houslay, M. D., & Baillie, G. S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.02.006 · Cited by 103
Self-citation
Genes and Schizophrenia: Beyond Schizophrenia: The Role of DISC1 in Major Mental Illness
Hennah, W., Thomson, P. A., Peltonen, L., & Porteous, D. J. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj079 · Cited by 103
Self-citation
A Dopamine D2 Receptor-DISC1 Protein Complex may Contribute to Antipsychotic-Like Effects
Su, P., Li, S., Chen, S., Lipina, T. V., Wang, M., Lai, T. K. Y., Lee, F. H. F., Zhang, H., Zhai, D., Ferguson, S. S. G., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.11.007 · Cited by 104
Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia
Crabtree, G. W., & Gogos, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00028 · Cited by 106
DISC1-dependent Regulation of Mitochondrial Dynamics Controls the Morphogenesis of Complex Neuronal Dendrites
Norkett, R., Modi, S., Birsa, N., Atkin, T. A., Ivankovic, D., Pathania, M., Trossbach, S. V., Korth, C., Hirst, W. D., & Kittler, J. T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.699447 · Cited by 104
Schizophrenia susceptibility genes: emergence of positional candidates and future directions
Gogos, J. A., & Gerber, D. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.02.005 · Cited by 103
Extracellular and Intracellular Signaling for Neuronal Polarity
Namba, T., Funahashi, Y., Nakamuta, S., Xu, C., Takano, T., & Kaibuchi, K. (2015) · Physiological Reviews · doi:10.1152/physrev.00025.2014 · Cited by 105
The role of neurexins in schizophrenia and autistic spectrum disorder
Reichelt, A. C., Rodgers, R. J., & Clapcote, S. J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.024 · Cited by 110
Altered axonal targeting and short-term plasticity in the hippocampus of Disc1 mutant mice
Kvajo, M., McKellar, H., Drew, L., Lepagnol-Bestel, A.-M., Xiao, L., Levy, R. J., Blazeski, R., Arguello, P. A., Lacefield, C., Mason, C. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114113108 · Cited by 103
The Role of DNA Copy Number Variation in Schizophrenia
Tam, G. W. C., Redon, R., Carter, N. P., & Grant, S. G. N. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.027 · Cited by 98
The Role of Phosphodiesterases in Schizophrenia
Siuciak, J. A. (2008) · CNS Drugs · doi:10.2165/0023210-200822120-00002 · Cited by 99
PDE4B as a microglia target to reduce neuroinflammation
Pearse, D. D., & Hughes, Z. A. (2016) · Glia · doi:10.1002/glia.22986 · Cited by 98
Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics
de Waal, L., Lewis, T. A., Rees, M. G., Tsherniak, A., Wu, X., Choi, P. S., Gechijian, L., Hartigan, C., Faloon, P. W., Hickey, M. J., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1984 · Cited by 96
cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor
Fujita, M., Richards, E. M., Niciu, M. J., Ionescu, D., Zoghbi, S. S., Hong, J., Telu, S., Hines, C. S., Pike, V. W., Zarate, C. A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.171 · Cited by 96
The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
Paes, D., Schepers, M., Rombaut, B., van den Hove, D., Vanmierlo, T., & Prickaerts, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000273 · Cited by 98
Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches
Ikeda, M., Tomita, Y., Mouri, A., Koga, M., Okochi, T., Yoshimura, R., Yamanouchi, Y., Kinoshita, Y., Hashimoto, R., Williams, H. J., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.030 · Cited by 96
Role of DISC1 in neural development and schizophrenia
Mackie, S., Millar, J. K., & Porteous, D. J. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.01.007 · Cited by 94
Self-citation
DISC1 complexes with TRAK1 and Miro1 to modulate anterograde axonal mitochondrial trafficking
Ogawa, F., Malavasi, E. L., Crummie, D. K., Eykelenboom, J. E., Soares, D., Mackie, S., Porteous, D., & Millar, J. K. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt485 · Cited by 102
Self-citation
Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights
Zamanpoor, M. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000245 · Cited by 96
The PDE4B gene confers sex-specific protection against schizophrenia
Pickard, B. S., Thomson, P. A., Christoforou, A., Evans, K. L., Morris, S. W., Porteous, D. J., Blackwood, D., & Muir, W. J. (2007) · Psychiatric Genetics · doi:10.1097/ypg.0b013e328014492b · Cited by 92
Self-citation
Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3
Lipina, T. V., Kaidanovich‐Beilin, O., Patel, S., Wang, M., Clapcote, S. J., Liu, F., Woodgett, J. R., & Roder, J. (2010) · Synapse · doi:10.1002/syn.20839 · Cited by 92
Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain
Wood, J. D., Bonath, F., Kumar, S., Ross, C. A., & Cunliffe, V. T. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn361 · Cited by 91
Neuroimaging genetics: New perspectives in research on major depression?
Frodl, T., Möller, H. ‐., & Meisenzahl, E. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01225.x · Cited by 87
Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia
Rodríguez-Santiago, B., Brunet, A., Sobrino, B., Serra-Juhé, C., Flores, R., Armengol, L., Vilella, E., Gabau, E., Guitart, M., Guillamat, R., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.53 · Cited by 88
Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme
Siuciak, J., Chapin, D., McCarthy, S. A., & Martin, A. N. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0727-x · Cited by 97
Association of the Ser704Cys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding
Giorgio, A. D., Blasi, G., Sambataro, F., Rampino, A., Papazacharias, A., Gambi, F., Romano, R., Caforio, G., Rizzo, M., Latorre, V., et al. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06482.x · Cited by 86
Concise Review: The Promise of Human Induced Pluripotent Stem Cell-Based Studies of Schizophrenia
Brennand, K., & Gage, F. H. (2011) · Stem Cells · doi:10.1002/stem.762 · Cited by 87
Spatial control of cAMP signalling in health and disease
Zaccolo, M. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.014 · Cited by 85
Neuronal migration abnormalities and its possible implications for schizophrenia
Muraki, K., & Tanigaki, K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00074 · Cited by 92
Deletion Polymorphism of Disc1 Is Common to All 129 Mouse Substrains: Implications for Gene-Targeting Studies of Brain Function
Clapcote, S. J., & Roder, J. (2006) · Genetics · doi:10.1534/genetics.106.060749 · Cited by 84
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
Jin, S.-L. C., Lin, S., & Ding, S.-L. (2012) · Biomedical Journal · doi:10.4103/2319-4170.106152 · Cited by 84
Impact of DISC1 variation on neuroanatomical and neurocognitive phenotypes
Carless, M., Glahn, D., Johnson, M. P., Curran, J., Bozaoglu, K., Dyer, T., Winkler, A., Cole, S., Almasy, L., Maccluer, J., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.37 · Cited by 92
Association Between Genes of Disrupted in Schizophrenia 1 (DISC1) Interactors and Schizophrenia Supports the Role of the DISC1 Pathway in the Etiology of Major Mental Illnesses
Tomppo, L., Hennah, W., Lahermo, P., Loukola, A., Tuulio-Henriksson, A., Suvisaari, J., Partonen, T., Ekelund, J., Lönnqvist, J., & Peltonen, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.014 · Cited by 93
The effects of arousal on apical amplification and conscious state
Phillips, W. A., Larkum, M. E., Harley, C. W., & Silverstein, S. M. (2016) · Neuroscience of Consciousness · doi:10.1093/nc/niw015 · Cited by 75
Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice
Lipina, T. V., Wang, M., Liu, F., & Roder, J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.020 · Cited by 83
Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models
Samsom, J., & Wong, A. H. C. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00013 · Cited by 88
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes
Kelly, M. P., Logue, S. F., Brennan, J. A., Day, J. P., Lakkaraju, S., Jiang, L., Zhong, X., Tam, M., Rizzo, S. J. S., Platt, B. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000730107 · Cited by 82
Self-citation
Animal models of gene–environment interaction in schizophrenia: A dimensional perspective
Ayhan, Y., McFarland, R., & Pletnikov, M. V. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.002 · Cited by 82
The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder
Arnsten, A. F. T. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.133 · Cited by 83
Synaptic Dysfunction in Schizophrenia
Yin, D., Chen, Y., Sathyamurthy, A., Xiong, W., & Mei, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_22 · Cited by 85
Mechanisms underlying the role of DISC1 in synaptic plasticity
Tropea, D., Hardingham, N. R., Millar, K., & Fox, K. D. (2018) · The Journal of Physiology · doi:10.1113/jp274330 · Cited by 77
Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia
Mathieson, I., Munafo, M. R., & Flint, J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.41 · Cited by 81
PKA Phosphorylation of NDE1 Is DISC1/PDE4 Dependent and Modulates Its Interaction with LIS1 and NDEL1
Bradshaw, N., Soares, D., Carlyle, B., Ogawa, F., Davidson-Smith, H., Christie, S., Mackie, S., Thomson, P., Porteous, D., & Millar, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5410-10.2011 · Cited by 95
Self-citation
Rethinking the genetic architecture of schizophrenia
Mitchell, K. J., & Porteous, D. J. (2010) · Psychological Medicine · doi:10.1017/s003329171000070x · Cited by 82
Self-citation
Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition
McGirr, A., Lipina, T. V., Mun, H.-S., Georgiou, J., Al-Amri, A. H., Ng, E., Zhai, D., Elliott, C., Cameron, R. T., Mullins, J. G. L., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.240 · Cited by 79
Self-citation
Non-Coding RNAs in Psychiatric Disorders and Suicidal Behavior
Yoshino, Y., & Dwivedi, Y. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.543893 · Cited by 85
The genie in the bottle-magnified calcium signaling in dorsolateral prefrontal cortex
Arnsten, A. F. T., Datta, D., & Wang, M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00973-3 · Cited by 79
Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders: Biochemical and Behavioral Profiles of Phosphodiesterase Inhibition in Dopaminergic Neurotransmission
Nishi, A., & Snyder, G. L. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10r01fm · Cited by 82
Type 4 Phosphodiesterase Plays Different Integrating Roles in Different Cellular Domains in Pyramidal Cortical Neurons
Castro, L. R., Gervasi, N., Guiot, E., Cavellini, L., Nikolaev, V. O., Paupardin‐Tritsch, D., & Vincent, P. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5851-09.2010 · Cited by 78
The DISC1 Pathway Modulates Expression of Neurodevelopmental, Synaptogenic and Sensory Perception Genes
Hennah, W., & Porteous, D. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004906 · Cited by 80
Self-citation
The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression
Azevedo, J. A., Carter, B. S., Meng, F., Turner, D. L., Dai, M., Schatzberg, A. F., Barchas, J. D., Jones, E. G., Bunney, W. E., Myers, R., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.012 · Cited by 84
DISC1, PDE4B, and NDE1 at the centrosome and synapse
Bradshaw, N. J., Ogawa, F., Antolin‐Fontes, B., Chubb, J. E., Carlyle, B. C., Christie, S., Claessens, A., Porteous, D. J., & Millar, J. K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.120 · Cited by 78
Self-citation
Local cAMP signaling in disease at a glance
Gold, M. G., Gonen, T., & Scott, J. D. (2013) · Journal of Cell Science · doi:10.1242/jcs.133751 · Cited by 82
Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1
Hennah, W., Tomppo, L., Hiekkalinna, T., Palo, O. M., Kilpinen, H., Ekelund, J., Tuulio‐Henriksson, A., Silander, K., Partonen, T., Paunio, T., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl462 · Cited by 78
Phosphodiesterases in the Central Nervous System
Kleppisch, T. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5_5 · Cited by 79
A Simple Cell-Based Assay Reveals That Diverse Neuropsychiatric Risk Genes Converge on Primary Cilia
Marley, A., & von Zastrow, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046647 · Cited by 78
Gene models of schizophrenia: DISC1 mouse models
Jaaro-Peled, H. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17909-8 · Cited by 83
Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner
Ramsey, A., Milenkovic, M., Oliveira, A. F., Escobedo-Lozoya, Y., Seshadri, S., Salahpour, A., Sawa, A., Yasuda, R., & Caron, M. (2011) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1012621108 · Cited by 83
Role of phosphodiesterases in neurological and psychiatric disease
Hebb, A. L. O., & Robertson, H. A. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.014 · Cited by 75
Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations
Heckman, P. R. A., Blokland, A., Bollen, E., & Prickaerts, J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.007 · Cited by 80
Disrupted-in-Schizophrenia 1–mediated axon guidance involves TRIO-RAC-PAK small GTPase pathway signaling
Chen, S.-Y., Huang, P.-H., & Cheng, H.-J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018128108 · Cited by 73
Differential Expression of Disrupted-in-Schizophrenia (DISC1) in Bipolar Disorder
Maeda, K., Nwulia, E. A., Chang, J. T., Balkissoon, R., Ishizuka, K., Chen, H., Zandi, P. P., McInnis, M. G., & Sawa, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.032 · Cited by 72
Association of PDE4B polymorphisms and schizophrenia in Northwestern Han Chinese
Guan, F., Zhang, C., Wei, S., Zhang, H., Gong, X., Feng, J., Gao, C., Su, R., Yang, H., & Li, S. (2011) · Human Genetics · doi:10.1007/s00439-011-1120-8 · Cited by 71
Synaptic functions and their disruption in schizophrenia: From clinical evidence to synaptic optogenetics in an animal model
Obi-Nagata, K., Temma, Y., & Hayashi‐Takagi, A. (2019) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.95.014 · Cited by 72
Detection of circular RNA expression and related quantitative trait loci in the human dorsolateral prefrontal cortex
Liu, Z., Ran, Y., Tao, C., Li, S., Chen, J., & Yang, E. (2019) · Genome biology · doi:10.1186/s13059-019-1701-8 · Cited by 69
An Odor-Specific Threshold Deficit Implicates Abnormal Intracellular Cyclic AMP Signaling in Schizophrenia
Turetsky, B. I., & Moberg, P. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071210 · Cited by 71
Constitutive Activation of Gαs within Forebrain Neurons Causes Deficits in Sensorimotor Gating Because of PKA-Dependent Decreases in cAMP
Kelly, M. P., Isiegas, C., Cheung, Y.-F., Tokarczyk, J., Yang, X., Esposito, M. F., Rapoport, D. A., Fabian, S., Siegel, S. J., Wand, G. S., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301099 · Cited by 72
Self-citation
NMDA receptor regulates migration of newly generated neurons in the adult hippocampus via Disrupted‐In‐Schizophrenia 1 (DISC1)
Namba, T., Ming, G., Song, H., Waga, C., Enomoto, A., Kaibuchi, K., Kohsaka, S., & Uchino, S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07282.x · Cited by 70
Oligomer Assembly of the C-Terminal DISC1 Domain (640−854) Is Controlled by Self-Association Motifs and Disease-Associated Polymorphism S704C
Leliveld, S. R., Hendriks, P., Michel, M., Sajnani, G., Bader, V., Trossbach, S. V., Prikulis, I., Hartmann, R., Jonas, E., Willbold, D., et al. (2009) · Biochemistry · doi:10.1021/bi900901e · Cited by 70
Fibroblast growth factor receptor signaling affects development and function of dopamine neurons – inhibition results in a schizophrenia‐like syndrome in transgenic mice
Klejbor, I., Myers, J. M., Hausknecht, K., Corso, T. D., Gambino, A. S., Moryś, J., Maher, P., Hard, R., Richards, J. C., Stachowiak, E., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03754.x · Cited by 76
A Single Nucleotide Polymorphism Fine Mapping Study of Chromosome 1q42.1 Reveals the Vulnerability Genes for Schizophrenia, GNPAT and DISC1: Association with Impairment of Sustained Attention
Liu, Y., Fann, C. S. J., Liu, C., Chen, W. J., Wu, J., Chung, W., Chen, C., Jou, Y., Liu, S.-K., Hwang, T., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.024 · Cited by 70
DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1
Niwa, M., Cash-Padgett, T. V., Kubo, K.-I., Saito, A., Ishii, K., Sumitomo, A., Taniguchi, Y., Ishizuka, K., Jaaro-Peled, H., Tomoda, T., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.154 · Cited by 70
Phosphodiesterase 4B: Master Regulator of Brain Signaling
Tibbo, A. J., & Baillie, G. S. (2020) · Cells · doi:10.3390/cells9051254 · Cited by 68
Self-citation
Loss-of-function variants in the schizophrenia risk gene SETD1A alter neuronal network activity in human neurons through the cAMP/PKA pathway
Wang, S., van Rhijn, J.-R., Akkouh, I. A., Kogo, N., Maas, N., Bleeck, A., Ortiz, I. S., Lewerissa, E., Wu, K. M., Schoenmaker, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110790 · Cited by 69
Selective Phosphodiesterase 4B Inhibitors: A Review
Azam, M. A. (2014) · Scientia Pharmaceutica · doi:10.3797/scipharm.1404-08 · Cited by 68
Tissue distribution and functional analyses of the constitutively active orphan G protein coupled receptors, GPR26 and GPR78
Jones, P. M., Nawoschik, S. P., SREEKUMAR, K., Uveges, A. J., Tseng, E., ZHANG, L., Johnson, J. L., He, L., Paulsen, J. E., & Bates, B. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.01.013 · Cited by 67
Sequencing of DISC1 Pathway Genes Reveals Increased Burden of Rare Missense Variants in Schizophrenia Patients from a Northern Swedish Population
Moens, L., Rijk, P. D., Reumers, J., Bossche, M. V. D. V. D., Glassee, W., Zutter, S. D., Lenaerts, A.-S., Nordin, A., Nilsson, L., Castello, I. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023450 · Cited by 67
DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan
Porteous, D. J., Thomson, P. A., Millar, J. K., Evans, K. L., Hennah, W., Soares, D. C., McCarthy, S., McCombie, W. R., Clapcote, S. J., Korth, C., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.160 · Cited by 67
Self-citation
PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis
Wiescholleck, V., & Manahan‐Vaughan, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.17 · Cited by 65
Genetic background influences age-related decline in visual and nonvisual retinal responses, circadian rhythms, and sleep
Banks, G. T., Heise, I., Starbuck, B., Osborne, T., Wisby, L., Potter, P. K., Jackson, I. J., Foster, F., Peirson, S. N., & Nolan, P. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.040 · Cited by 66
A t(1;11) translocation linked to schizophrenia and affective disorders gives rise to aberrant chimeric DISC1 transcripts that encode structurally altered, deleterious mitochondrial proteins
Eykelenboom, J. E., Briggs, G. J., Bradshaw, N. J., Soares, D. C., Ogawa, F., Christie, S., Malavasi, E. L. V., Makedonopoulou, P., Mackie, S., Malloy, M. P., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds169 · Cited by 64
Self-citation
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias
van der Westhuizen, E. T., Choy, K. H. C., Valant, C., McKenzie-Nickson, S., Bradley, S. J., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.606656 · Cited by 63
Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Gαs, a G-protein subunit genetically linked to schizophrenia
Kelly, M. P., Stein, J. M., Vecsey, C. G., Favilla, C. G., Yang, X., Bizily, S. P., Esposito, M., Wand, G. S., Kanes, S., & Abel, T. G. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.124 · Cited by 65

Authors: Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., Thomson, P. A., Hill, E. V., Brandon, N. J., Rain, J.-C., Camargo, L. M., Whiting, P. J., Houslay, M. D., Blackwood, D. H. R., Muir, W. J., & Porteous, D. J.
Affiliations: Royal Edinburgh Hospital (GB)
Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh EH4 2XU, UK.
Corresponding author: Millar, J. Kirsty
ORCID: James, Rachel
Baillie, George S.
Thomson, Pippa A.
Brandon, Nicholas J.
Rain, Jean-Christophe
Camargo, L. Miguel
Whiting, Paul J.
Houslay, Miles D.
Blackwood, Douglas H. R.
Porteous, David J.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2005-11-18
Volume: 310
Issue: 5751
Pages: 1187-1191
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1112915
OpenAlex: W2105051672
Cited by: 648
References: 20
Citations by year: 2026: 7 · 2025: 7 · 2024: 12 · 2023: 11 · 2022: 14 · 2021: 13 · 2020: 14 · 2019: 19 · 2018: 21 · 2017: 24 · 2016: 28 · 2015: 47 · 2014: 39 · 2013: 24 · 2012: 35
FWCI: 20.82
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Wellcome Trust
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords: DISC1, PDE4B, schizophrenia, cAMP signaling, phosphodiesterase 4, balanced translocation, protein-protein interaction, second messengers, genetic susceptibility, chronic mental illness
MeSH terms: Cyclic AMP, Adult, Affective Disorders, Psychotic, Animals, Cell Line, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 16, Enzyme Activation, Humans, Male, Nerve Tissue Proteins, Protein Binding, Schizophrenia, Translocation, Genetic, 3',5'-Cyclic-AMP Phosphodiesterases, Signal Transduction, Cadherins, Genetic Predisposition to Disease, Rats, Cyclic Nucleotide Phosphodiesterases, Type 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks